1. Ari A. Aerosol Therapy in Pulmonary Critical Care. Respiratory Care. 2015;60(6):
858–879. 2. Bajwa SS, Baruah MP, Kalra S, Kapoor MK. Guidelines on Inpatient Management of Hyperglycemia. In: Muruganathan A. (ed.) Medicine Update. Vol. 23. Mumbai: Association of Physicians of India; 2013: 164–169. 3. Bilgrami I, Roberts JA, Wallis SC, Thomas J, Davis J, Fowler S. Meropenem Dosing in Critically Ill Patients with Sepsis Receiving High-Volume Continuous Venovenous Hemofiltration. Antimicrobial Agents and Chemotherapy. 2010;54(7): 2974–2978. 4. Bhagat A, Rachana. Bromhexine: A Comprehensive Review. International Journal of Biological and Medical Research. 2018;9(3): 6455–6459. 5. Chang CC, Cheng AC, Chang AB. Over-the-Counter (OTC) Medications to Reduce Cough as An Adjunct to Antibiotics for Acute Pneumonia in Children and Adults. Cochrane Database of Systematic Reviews. 2014;3(CD006088). 6. Ciesla WP, Guerrant RL. Infectious Diarrhea. In: Wilson WR, Drew WL, Henry NK, et al editors. Current Diagnosis and Treatment in Infectious Disease. New York: Lange Medical Books, 2003. 225 - 68. 7. DuPont HL, Ericsson CD, DuPont MW, Cruz Luna A, Mathewson JJ. A randomized, open-label comparison of nonprescription loperamide and attapulgite in the symptomatic treatment of acute diarrhea. The American Journal of Medicine. 1990; 88: 20S – 23S. 8. Febyan F, Tanpomas I, Suparto. Sepsis dan Tatalaksana Berdasar Guideline Terbaru. Jurnal Anestesiologi Indonesia. 2018;X(2): 102. 9. Freitag D, Bebee R, Sunderland B. Digoxin-quinidine and digoxine-amiodarone interactions: frequency of occurence and monitoring in Australian repatriation hospitals. Journal of Clinical Pharmacy and Therapeutics. 1995;20: 179–183 10. Guerrant RL, Gilder TV, Steiner TS, et al. Practice Guidelines for the Management of Infectious Diarrhea. Clinical Infectious Diseases 2001;32:331-51. 11. Gustaviani reno, Suyono slamet, Soebardi suharko, Waspadji sarwono,Yunir em, Soegondo sidartawan. Buku ajar ilmu penyakit dalam jilid III edisi 4. Diabetes mellitus di Indonesia, diagnosis dan klasifikasi diabetes, farmakoterapi dan terapi non farmakologis DM tipe 2, komplikasi kronik diabetes. Jakarta : FKUI; 2007 h. 1852-86. 12. Giamarellos-Bourboulis EJ, Spyridaki A, Savva A, Georgitsi M, Tsaganos T, et al. Intravenous Paracetamol as an Antipyretic and Analgesic Medication: the Significance of Drug Metabolism. Journal of Pharmacological Sciences. 2014;124: 144–152. 13. Gorji HM, Gorji NM, Vasel A, Rahimi B. The Effect of Proton Pump Inhibitors on Glycemic Control in Patients with Type II Diabetes. Journal of Clinical and Analytical Medicine. 2017;8(Supplement 5): 504–508. 14. Holliday MA, Segar WE. The maintenance need for water in parenteral fluid therapy. Pediatrics. 1957;19(5): 823–832. 15. In: Gallo A, et al, editors. Intensive and Critical Care Medicine. Springer-Verlag Italia, 2009; p. 299-309. 16. Lung E, Acute Diarrheal Disease. In: Friedman SL, McQuaid KR, Grendell JH, editors. nd Current Diagnosis and Treatment in Gastroenterology. 2 edition. New York: Lange Medical Books, 2003. 131 - 50. 17. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation. Journal of the American College of Cardiology. 2014;64(21): e1–e76. 18. Nathalie M, Dhainaut JF. Sepsis and acute lung injury. In: Dhainaut JF, et al, editors. Septic shock. WB Saunders Company Limited, 2000; p. 211–45. 19. Nebraska Medicine. Antibiotic Protocol for Empiric Therapy of Community-Acquired Pneumonia (CAP). Omaha, NE: Nebraska Medicine; 2015. 20. Nguyen B, et al. Severe sepsis and septic shock: Review of the literature and emergency. Department management guidelines. Annals of Emergency Medicine. 2006; 48(1): 28-54. 21. Orbach S, et al. The pa! ent with sepsis or the Systemic Inflamatory Respons Syndrome. In: Murray MJ, et al, editors. Critical care medicine: Perioperative management. 2nd ed. Lippinco' Williams&Wilkins, 2002; p. 601-15. 22. Pedoman Pemberantasan Penyakit Diare. Mentri Kesehatan Republik Indonesia. Available from :http://www.depkes.go.id/downloads/SK1216-01.pdf 23. Rani A.Aziz, Nafrialdi, dkk. Panduan Pelayanan Medik PB PAPDI. Jakarta : Departemen Ilmu Penyakit Dalam FKUI, Agustus 2008. 24. Prakash S, Aggarwal M. Rate of Administration of Intravenous Ondansetron. Indian Journal of Anaesthesia. 2011;55(4): 426–427. 25. PDR. Seftriakson. Tersedia di https://www.pdr.net/drug-summary/Seftriakson- seftriakson-1723.4059. Diakses 11 Desember 2018. Peker E, Cagan E, Dogan M. Ceftriaxone-induced Toxic Hepatitis. World Journal of Gastroenterology. 2009;15(21): 2669-2671.